NCT05149599View on ClinicalTrials.gov

Saccharomyces Cerevisiae for Irritable Bowel Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Saccharomyces cerevisiae

Saccharomyces cerevisiae, which is a pro-biotic, was given in capsule form, 500mg twice daily for 1 month

Trial Locations (1)

75600

Dr. Ziauddin University Hospital Clifton, Karachi

Sponsors

Collaborators (1)

Hilton Pharma
All Listed Sponsors
collaborator

Hilton Pharma

INDUSTRY

lead

Ziauddin University

OTHER

NCT05149599 - Saccharomyces Cerevisiae for Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter